Floatz logo

IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER

Pediatric Cancer

AstraZenecamonoclonal_antibodyPhase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

32 Active assets in the Pediatric Cancer cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Tianjin Medical University Cancer Institute and Hospital
Phase 2BB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 2BB
Nivolumab
Australian & New Zealand Children's Haematology/Oncology Group
Phase 2B
Carboplatin
Samsung Medical Center
Phase 2B
gw786034
Samsung Medical Center
Phase 2B

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER is also rated in:

malignant pancreatic neoplasmDormant
BB
Indicative ·
68 / 100
View asset →
Borderline Resectable Pancreatic Ductal AdenocarcinomaDormant
BB
Indicative ·
66 / 100
View asset →
pancreatic ductal adenocarcinomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →